A 5 Year Clinical Investigation on Creos Xenoprotect

NCT02373787 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2017-11-13

No results posted yet for this study

Summary

A 5-year clinical investigation on creos xenoprotect

Conditions

  • Implant

Interventions

DEVICE

creos xenoprotect

Implant placement with simultaneous bone augmentation

DEVICE

Bio-Gide

resorbable collagen membrane

Sponsors & Collaborators

  • Nobel Biocare

    lead INDUSTRY

Principal Investigators

  • Isabelle Arrighi, PhD · Nobel Biocare Services AG

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-01-28
Completion
2017-10-02

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02373787 on ClinicalTrials.gov